Recombinant Human HDAC6 Protein，His

Histone deacetylase 6 (HDAC6) is a cytoplasmic enzyme that plays a crucial role in regulating various cellular processes, including protein degradation, cytoskeletal dynamics, and stress responses. Unlike classical HDACs that primarily target histones, HDAC6 uniquely deacetylates non-histone proteins, such as tubulin and heat shock protein 90 (HSP90), thereby influencing cell motility and apoptosis. Overexpression of HDAC6 has been linked to several pathological conditions, particularly cancer and neurodegenerative diseases, where its activity can promote tumor progression and neurotoxic responses. Given its significant involvement in these diseases, HDAC6 has emerged as a promising therapeutic target. Researchers are increasingly focused on the development of HDAC6 inhibitors, which may offer novel treatment strategies for conditions characterized by dysregulated acetylation. Exploring the structural and functional properties of recombinant HDAC6 proteins allows for a better understanding of its enzymatic mechanisms and interactions with substrates, which is essential for rational drug design. Additionally, the study of HDAC6's role in cellular signaling pathways has potential implications in the fields of regenerative medicine and immunology. As such, the comprehensive understanding of HDAC6 function and modulation can pave the way for innovative therapeutic interventions aimed at mitigating the impact of its dysregulation in various diseases.